Consistent with the results obtained with other inactive virus particles used as tumor vaccines [37], we also showed that mMSLN-VLP immunization can reduce the frequency of Tregs which alleviated their suppressive effect on CD8+ T cells and thus reduce the tumor burden in mice. The gene discussed is CD8A; the disease is neoplasm.